BioAtla, Inc. (BCAB)
Biological Products, (No Diagnostic Substances)
Latest Price
$1.74
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
0.01
P/B Ratio
184.57
Institutional Ownership
10.4% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 70.6K | -- | 4.25% | -- | 2026-06-30 |
| Lido Advisors, LLC | 16.7K | -- | 1.00% | -- | 2026-06-30 |
| Stonepine Capital Management, LLC | 16.4K | -- | 0.99% | -- | 2026-06-30 |
| HRT FINANCIAL LP | 13.3K | -- | 0.80% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 12.8K | -- | 0.77% | -- | 2026-06-30 |
| DEUTSCHE BANK AG\ | 10.6K | -- | 0.63% | -- | 2026-06-30 |
| BlackRock, Inc. | 9.6K | -- | 0.58% | -- | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 9.2K | -- | 0.55% | -- | 2026-06-30 |
| UBS Group AG | 6.2K | -- | 0.37% | -- | 2026-06-30 |
| VANGUARD FIDUCIARY TRUST CO | 4.7K | -- | 0.28% | -- | 2026-06-30 |